Regenxbio (RGNX) Stock Plummets 25% as FDA Halts Gene Therapy Trial
Regenxbio (RGNX) stock crashed 25% after FDA halted RGX-121 gene therapy trials due to spinal MRI findings in five patients treate...
Archer Aviation (ACHR) Stock Soars 19% Following L.A. Live Vertiport Partnership...
Archer Aviation (ACHR) stock rises 19% in a month after securing L.A. Live vertiport deal. Analysts target $11.60 as Olympic air t...
Bernstein Boosts Airbnb (ABNB) Price Target to $217 Following Strong Q2 Performa...
Bernstein raises Airbnb (ABNB) price target to $217, citing accelerating night growth and Q2 earnings beat as signs of a clear tur...
Taiwan Charges Nvidia (NVDA) and Super Micro Staff in Illegal AI Chip Export Cas...
Taiwan indicts nine people, including Nvidia and Super Micro employees, for smuggling advanced AI servers to China using fraudulen...
American Airlines (AAL) Stock Falls After Q4 Capacity Forecast Reduced Amid Trav...
American Airlines (AAL) cuts Q4 capacity forecast to 6.5% amid falling TSA numbers, while institutional buyers add $119M stake. St...
Dick’s Sporting Goods (DKS) Q2 Earnings Preview: Foot Locker Integration Takes C...
Dick's Sporting Goods (DKS) reports Q2 earnings Tuesday. Analysts expect $3.78 EPS and $5.65B revenue as Foot Locker acquisition p...
Visa (V) Stock Surges to 52-Week Peak Amid Strong Analyst Backing
Visa (V) stock climbed to a 52-week high of $374.20, driven by strong Q3 earnings, double-digit revenue growth, and bullish analys...
XPeng (XPEV) Stock: Falls 6.8% Despite $900 Million Robotics Funding Boost
TLDR XPeng shares slide 6.8% even as its robotics unit secures over $900 million. XPeng robotics reaches a valuation above $6.3 bi...
Pfizer (PFE) Stock: Analysts Lean Bullish Despite Lingering Valuation Questions
Pfizer (PFE) stock trades at 9.4x 2026 earnings with a 6.1% dividend yield. Wall Street says Moderate Buy, but valuation questions...
CrowdStrike (CRWD) Stock: Wall Street Anticipates 8% Volatility on Q2 Earnings R...
CrowdStrike (CRWD) reports Q2 earnings Wednesday. Analysts expect $1.44B revenue, 8% stock movement, and raised price targets amid...